Man Survives Days Without Lungs, Pioneering Recent Treatment for Severe Pneumonia
In a remarkable feat of modern medicine, a 33-year-old man survived for two days without lungs, sustained by an external artificial lung system. This groundbreaking case, initially stemming from a common flu that rapidly escalated into severe bacterial pneumonia and acute respiratory distress syndrome (ARDS), offers hope for patients with irreversible lung damage.
From Flu to Life Support
The patient’s condition deteriorated quickly, leading to severe acute respiratory distress syndrome (ARDS), which caused complete lung failure and subsequent heart and kidney dysfunction. His lungs were irreversibly damaged, and the infection was spreading, necessitating a drastic intervention: the complete removal of both lungs.
Extracorporeal Membrane Oxygenation (ECMO) as a Bridge to Transplant
Surgeons at Northwestern University, led by thoracic surgeon Ankit Bharat, made the decision to remove both lungs. The patient was then maintained on an external artificial lung system, known as extracorporeal membrane oxygenation (ECMO). ECMO temporarily takes over the function of the lungs, oxygenating the blood, removing carbon dioxide, and supporting circulation.
Recovery and Successful Lung Transplant
Following the lung removal, the patient’s condition began to stabilize. His blood pressure normalized, other organs started to recover, and the infection came under control. Within two days, a suitable donor lung became available, and a successful double lung transplant was performed. More than two years post-surgery, the patient is now living a normal life with fully functional lungs.
ARDS and Pneumonia: A Dangerous Combination
ARDS, often triggered by infections like pneumonia, is a life-threatening condition characterized by fluid buildup in the lungs, making it challenging to breathe. Pulmonary infections can complicate ARDS, and atypical pathogens like Aspergillus, herpes simplex virus, and cytomegalovirus may also be responsible for infection in ARDS patients.
Secondary Bacterial Pneumonia in Severe Respiratory Illness
Severe pneumonia, including cases stemming from infections like COVID-19, can often lead to secondary bacterial pneumonia, which can be more deadly than the initial viral infection. Research highlights the importance of preventing, detecting, and aggressively treating secondary bacterial pneumonia in critically ill patients.
The Lung Microbiome and Pneumonia Recovery
Recent research is also shedding light on the role of the lung microbiome in pneumonia recovery. Studies have identified distinct microbial patterns, or “pneumotypes,” associated with different types of pneumonia, including community-acquired, hospital-acquired, and ventilator-acquired pneumonia. Patients most likely to recover often share characteristics such as lung microbiomes resembling oral microbiomes and dynamic, rather than stable, microbial communities.
Future Implications
While currently feasible only in specialized, well-equipped hospitals, surgeons hope this approach will become a more widely available treatment option for patients facing irreversible lung failure. This case demonstrates the potential for innovative therapies to extend life and offer hope in the face of devastating respiratory illnesses.